MacMillan EL, Russell-Schulz B, Alejo G, Harp C, et al. Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab. Mult Scler 2026 Jun 30:13524585261456964. doi: 10.1177/13524585261456964.
PMID: 42376811